KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Non-Current Liabilities (2016 - 2025)

Emergent BioSolutions' Total Non-Current Liabilities history spans 16 years, with the latest figure at $742.1 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 14.48% year-over-year to $742.1 million; the TTM value through Dec 2025 reached $742.1 million, down 14.48%, while the annual FY2025 figure was $742.1 million, 14.48% down from the prior year.
  • Total Non-Current Liabilities reached $742.1 million in Q4 2025 per EBS's latest filing, down from $835.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.7 billion in Q4 2022 to a low of $742.1 million in Q4 2025.
  • Average Total Non-Current Liabilities over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: surged 43.51% in 2023, then tumbled 35.48% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $1.3 billion in 2021, then surged by 36.06% to $1.7 billion in 2022, then plummeted by 34.09% to $1.1 billion in 2023, then fell by 24.21% to $867.8 million in 2024, then decreased by 14.48% to $742.1 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Total Non-Current Liabilities are $742.1 million (Q4 2025), $835.9 million (Q3 2025), and $841.4 million (Q2 2025).